INSUBCONTINENT EXCLUSIVE:
However, Eko, a startup best known for creating an electronic stethoscope to monitor your heart rhythm, hopes further research and
development will help give its more clinically promoted device a leg up as a leader in the fight against heart disease.To get there, the
company recently closed on a $20 million round of Series B financing, led by Artis Ventures
and XTX Ventures.On top of that, the company has teamed up with some well-known health partners, such as the Mayo Clinic, Northwestern
great strides in cardiac care in the last decade
even more necessary.It also does more than just test your heart rate, Eko co-founder and COO Jason Berler told TechCrunch
market today, it seems to grasp the need to go beyond a simple heart-rate app for further knowledge on determining heart health through
partner Vasudev Bailey said in a statement
This demonstrates the potential for an immense pipeline of life-saving applications where sound can aid in the screening of many other
